| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.00026 | 1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.00037 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.00013 | 1 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.00011 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.00016 | 1 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -6.7e-05 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -5.2e-05 | 1 |